Atlas Trials

Study to Assess the Safety and Effectiveness of Beltavac® Polymerized With Alternaria Alternata

Clinical trial NCT03604718 · COMPLETED

Trial details

NCT number
NCT03604718
Sponsor
Probelte Pharma S.L.U.
Status
COMPLETED
Study type
OBSERVATIONAL
Rhinoconjunctivitis With or Without Allergic Asthma
Start date
2018-06-07
Primary completion
2023-01-20
Enrollment
65

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.